Coronavirus Knocks Drug Pricing Down – But Not Off – Political Priority List In US
• By Michael McCaughan
Coronovirus is taking attention away from drug pricing in US congressional hearings, but is also bringing visibility to the supply chain and national security issues. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
